Jump to section
Alyve's mission is to be the world's leading provider in feelings of wellbeing through personalised nutrition that is effective, affordable, and convenient for each individual.
The personalised supplement subscription market has shown remarkable growth over recent years. This is no surprise: it sits at the cross-section of some powerful market trends. The shift to ecommerce has made DTC and subscription models more appealing to both consumers and businesses; personalised products are becoming a key way of winning over younger consumer demographics, and the proportion of people taking supplements has soared to make up a substantial majority in Alyve’s home UK market.
So Alyve is onto a good thing here. Plus, whilst the US market is flooded with young startups looking to cash in on this niche, things aren’t so crowded in the UK. By importing the same model that’s brought the likes of Hims and Ro such success abroad, Alyve is laying down some firm business foundations.
The problem may be how to distinguish itself from competitors if things do get more crowded. In the US. we’re already seeing the market separate out into broader wellness businesses and specialist supplement programs. Alyve, along with UK competitors like Everyly and Vitamin Buddy, can currently get away with simple and remarkably similar offerings (although Alyve does offer blood tests for select vitamin levels) - but this may not last for long.
Freddie
Company Specialist at Welcome to the Jungle
Jan 2023
$0.2m
SEED
Feb 2022
$0.2m
EARLY VC
This company has top investors
Sam Price
(CEO)Co-founded mobile bar service The Bar Bros, before moving on to work in customer management at dotdigital and Canon EMEA.